Mood Disorders Information Center
Women with a good recovery after stroke and a moderate level of optimism had a 0.40‐fold reduction in the odds of developing new-onset poststroke depression.
Atypical antipsychotic adjunctive therapy and mood stabilizers may be a more effective treatment than mood stabilizer monotherapy.
Depression is common in patients receiving chronic hemodialysis but seems to be ineffectively treated.
Researchers measured vital status records to ascertain death from 16 site-specific malignancies.
Lithium has been the mainstay of treatment for decades, but several other classes of medication have recently been used with varying degrees of success.
Among all women, PPD risk increased with advanced age and gestational diabetes.
The declining rates for lithium use are linked to the burden of side effects and toxicity associated with the drug.
Men with diabetes, but not women, had excess mortality risk associated with depression and anxiety.
Some aspects of depression literacy were lower among patients with depression.
Comorbid panic disorder was linked to increased likelihood of side effects during treatment for depression.
Two studies found that psilocybin (magic mushrooms) treatment was effective for anxiety and depression.
The position statement provides recommendations for psychosocial assessment and care of individuals with diabetes.
Electroconvulsive therapy is effective for depression in patients with suicidal ideation and resistance to other treatments.
About one-third of patients with MCI are also diagnosed with depression.
The Mood Zoom questionnaire rates anxiety, elation, sadness, anger, irritability, and energy on a 7-point scale.